Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Filgotinib completely reversed hair loss in a patient with rheumatoid arthritis and alopecia universalis.

Rituximab improved her dermatomyositis better than usual treatments.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

GLP-1 receptor agonists may help or harm hair health, needing more research.

Low-level light therapy safely improves hair coverage, thickness, and count in androgenetic alopecia patients.

Correct diagnosis and treatment are crucial for effective management of lipid storage myopathies.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Flutamide alone is as effective as the combination with finasteride for treating hirsutism.

Deucravacitinib led to full hair regrowth in a severe alopecia areata patient.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

A patient's grey hair regained color during treatment with adalimumab.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Bicalutamide improves hair density in women safely.